These findings suggested that the abnormal DNA methylation of PNPLA3 and PARVB may play a crucial role in the fibrosis severity in patients with MASLD or chronic hepatitis C infection. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.